Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Peptide Retatrutide is an investigational research peptide currently being studied for its interaction with multiple metabolic hormone receptors
According to research from the Kaiser Family Foundation, 12% of Americans say they have taken a GLP-1 drug for weight loss, diabetes treatment, or to reduce the risk of heart attack or stroke
This approach can vary significantly from person to person, and it is essential to work closely with a clinician to determine the appropriate dosage
Lilly describes retatrutide as an investigational once-weekly triple hormone receptor agonist that is legally available only to participants in Lilly clinical trials
US$ 28.00
US$ 23.63
US$ 23.70
